Next Article in Journal / Special Issue
Goblet Cells and Mucins: Role in Innate Defense in Enteric Infections
Previous Article in Journal
Defensin Production by Human Limbo-Corneal Fibroblasts Infected with Mycobacteria
Article Menu

Export Article

Open AccessReview
Pathogens 2013, 2(1), 33-54; doi:10.3390/pathogens2010033

Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance

Department of Laboratory Medicine & Pathobiology, University of Toronto, Canada
Department of Pathology & Laboratory Medicine, The University of Calgary, Calgary, AB, Canada
Department of Microbiology, Immunology, and Infectious Diseases, The University of Calgary, Diagnostic & Scientific Centre, Room 1W-416, 9-3535 Research Road NW, Calgary, AB T2L 2K8, Canada
Author to whom correspondence should be addressed.
Received: 8 December 2012 / Revised: 18 January 2013 / Accepted: 23 January 2013 / Published: 4 February 2013
(This article belongs to the Special Issue Host-Parasite Interactions)
View Full-Text   |   Download PDF [623 KB, uploaded 4 February 2013]   |  


Malaria continues to exact a great human toll in tropical settings. Antimalarial resistance is rife and the parasite inexorably develops mechanisms to outwit our best drugs, including the now first-line choice, artesunate. Novel strategies to circumvent resistance are needed. Here we detail drug development focusing on heat shock protein 90 and its central role as a chaperone. A growing body of evidence supports the role for Hsp90 inhibitors as adjunctive drugs able to restore susceptibility to traditionally efficacious compounds like chloroquine.
Keywords: malaria; hsp90; antimalarial resistance malaria; hsp90; antimalarial resistance

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Shahinas, D.; Folefoc, A.; Pillai, D.R. Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance. Pathogens 2013, 2, 33-54.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top